9-21968734-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001195132.2(CDKN2A):c.495G>C(p.Arg165Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000553 in 1,536,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001195132.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000892 AC: 12AN: 134580Hom.: 0 AF XY: 0.0000409 AC XY: 3AN XY: 73302
GnomAD4 exome AF: 0.0000405 AC: 56AN: 1383832Hom.: 0 Cov.: 32 AF XY: 0.0000293 AC XY: 20AN XY: 682862
GnomAD4 genome AF: 0.000190 AC: 29AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74486
ClinVar
Submissions by phenotype
CDKN2A-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Melanoma-pancreatic cancer syndrome Benign:1
- -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at